echoloc

Ceribell │ AI-Powered Point-of-Care EEG Tech Stack

FDA-cleared portable EEG platform with AI-powered seizure detection for acute care

Medical Equipment Manufacturing Sunnyvale, California 201–500 employees Founded 2014 Public Company

Ceribell manufactures a point-of-care EEG device combining portable hardware with AI algorithms for rapid seizure detection in emergency and ICU settings. The tech stack reveals a medical-device manufacturer: embedded firmware (ARM Cortex, FreeRTOS), circuit design tools (Altium, KiCAD), and signal processing (MATLAB, C/C++), paired with enterprise software (Salesforce, NetSuite, AWS/GCP). Sales hiring significantly outpaces engineering, and active projects focus on customer expansion and compliance—signaling a post-launch, revenue-growth phase rather than product iteration.

Tech Stack 26 technologies

Core StackExpensify Salesforce AWS Python MATLAB SolidWorks Greenhouse NetSuite Lattice Power BI Concur GCP Ironclad Altium Eagle Allegro KiCAD C/C++ STM32 ARM Cortex FreeRTOS TouchGFX macOS Paylocity

What Ceribell │ AI-Powered Point-of-Care EEG Is Building

Challenges

  • Expanding into new departments
  • Expanding install base
  • Driving new and organic growth
  • Ensuring fedramp compliance
  • Secure cloud deployment
  • High-availability software
  • Acquisition process
  • Cost and time-saving processes
  • Legal department automation
  • Scaling backend for medical data

Active Projects

  • Eeg portal
  • Drive new product introductions for existing customers
  • Upgrade and departmental expansion
  • New department launches
  • Clinical champion development
  • Launch ceribell at new customer sites
  • Physician training
  • Fedramp compliance
  • Legal department automation
  • Corporate governance initiatives

Hiring Activity

Minimal15 roles · 0 in 30d

Department

Sales
9
Engineering
2
Legal
2
Executive
1

Seniority

Senior
7
Mid
4
Manager
2
Director
1
Company intelligence

Find more companies like Ceribell │ AI-Powered Point-of-Care EEG by tech stack, pain points and active projects

Get started free

About Ceribell │ AI-Powered Point-of-Care EEG

Ceribell develops the Ceribell System, an FDA 510(k)-cleared EEG platform for diagnosing and monitoring neurological conditions in acute care environments. The device combines proprietary hardware with AI-powered analysis to enable rapid seizure detection in intensive care units and emergency departments across the United States. Founded in 2014 and headquartered in Sunnyvale, California, the company operates as a public medical-device manufacturer with 201–500 employees. Current organizational priorities center on expanding clinical adoption across new hospital sites, scaling backend infrastructure for medical data, and achieving FedRAMP compliance for secure cloud deployment.

HeadquartersSunnyvale, California
Company Size201–500 employees
Founded2014
Hiring MarketsUnited States

Frequently Asked Questions

What technology does Ceribell use to build its EEG system?

Ceribell's platform uses embedded firmware (ARM Cortex, FreeRTOS), signal processing (MATLAB, C/C++), circuit design (Altium, KiCAD), and cloud infrastructure (AWS, GCP). The hardware runs on STM32 microcontrollers with TouchGFX for the user interface.

What is Ceribell working on in 2024?

Active projects include expanding the EEG portal, launching the system at new customer sites, physician training programs, achieving FedRAMP compliance, legal department automation, and scaling backend infrastructure to handle medical data at higher volumes.

Similar Companies in Medical Equipment Manufacturing

Other companies in the same industry, closest in size

How this profile is built

Ceribell │ AI-Powered Point-of-Care EEG's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.